Carbon nanotubes (CNTs) are nanomaterials with interesting emerging applications. Their 25 properties makes CNTs excellent candidates for use as new nanovehicles in drug delivery, immunization and diagnostics. In the current study, we assessed the immune-response-amplifying properties of CNTs to haptens by using azoxystrobin, the first developed strobilurin fungicide, as a model analyte. An azoxystrobin derivative bearing a carboxylated spacer arm (hapten AZc6) was covalently coupled to bovine serum albumin (BSA), and the resulting BSA-AZc6 conjugate was 30 covalently linked to four functionalized CNTs of different shapes and sizes, varying in diameter and length. These four types of CNT-based constructs were obtained using efficient, fast, and easy functionalization procedures based on microwave-assisted chemistry. New Zealand rabbits and BALB/c mice were immunized with BSA-AZc6 alone and with the four CNT-BSA-AZc6 constructs, both with and without Freund's adjuvant. The IgG-type antibody responses were assessed 35 in terms of the titer and affinity, paying special attention to the relationship between the immune response and the size and shape of the employed CNTs. Immunization with CNT-BSA-AZc6 resulted in enhanced titers and excellent affinities for azoxystrobin. More important, remarkable IgG responses were obtained even in the absence of an adjuvant, thus proving the self-adjuvanting capability of CNTs. Immunogens were able to produce strong anti-azoxystrobin immune responses 40 in rabbits even when administered at a BSA-AZc6 conjugate dose as low as 0.05 g. The short and thick CNT-BSA-AZc6 construct produced the best antibody response under all tested conditions.
Introduction
Enhancement of the immune response against antigens is an area of great interest because of its impact on antibody production. One of the key steps in the immunization process is the phagocytosis of the antigen by professional antigen-presenting cells (APCs), such as macrophages, dendritic cells, 50 and certain B cells. [1, 2] Once internalized by APCs, the antigen is processed into short peptide fragments. The presentation of these peptides by major histocompatibility complex (MHC) class II molecules can activate helper T cell responses that ultimately lead to the proliferation of plasma and memory B cells and to the production of high-affinity antibodies. [3] [4] [5] [6] The efficiency of the phagocytosis process mainly depends on the size and surface properties of 55 the antigen. Large and insoluble particulate antigens are phagocytosed very efficiently and produce strong responses by themselves. [7] [8] [9] This is the case for microorganisms such as bacteria and viruses. [10, 11] Conversely, small and soluble antigens, such as proteins and peptides, are poorly internalized and thus weakly immunogenic; therefore, an adjuvant is needed to intensify the immune response. [12, 13] Triggering an efficient immune response to low-molecular-weight compounds 60 (haptens) is an even more challenging task because they are smaller and lack a peptide structure, so they cannot be presented by MHC II molecules unless they are conjugated to proteins prior to immunization. [14, 15] One of the emerging strategies for increasing the efficiency of the phagocytosis step, thereby enhancing the antibody response, is the use of nanomaterials that can increase the size of the antigen 65 and modify its surface properties. Micro/nanoparticles (MPs/NPs) have been shown to be well-suited for increasing the immune response against protein and peptide antigens because the dimensions of particulate systems are comparable to those of microorganisms. Therefore, they can be better engulfed by APCs and the antigens can be delivered more efficiently. [16] There are basically two possible ways to take advantage of MPs/NPs for immunization purposes. One way consists of 70 encapsulating the antigen inside liposomes [17, 18] or inside organic biodegradable polymers, such as poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), [19] [20] [21] [22] [23] [24] disulfide cross-linked polyacrylates, [25] or polysaccharides, such as pullulan [26] and chitosan. [27] [28] [29] This way, the particles can easily reach cytosol, where they are degraded, thus releasing the antigen. The other approach consists of attaching the antigen (covalently or not) to the functionalized surface of 75 biocompatible and non-biodegradable particulate materials, such as lecithin NPs, [30] gold NPs,[31-33] quantum dots, [34] or MPs/NPs based on diverse organic polymers like polystyrene, [35, 36] polypropylene sulfide, [37] or polyacrylate. [38] Carbon nanotubes (CNTs) are nanomaterials of tubular shape with promising applications in biological and medicinal chemistry. [39] [40] [41] [42] [43] They are capable of crossing membranes to penetrate 80 into different types of cells without causing cell death, so both the cell functionality and the activity of the introduced molecules are preserved. [44] [45] [46] Based on this finding, CNTs have been successfully employed as nanovehicles for drug delivery [43, 47, 48] and for the transport of biomolecules, such as proteins, [49] peptides, [50] and DNA[42, 51, 52] , into cells. Additionally, based on their structural and chemical properties, CNTs can be envisioned as excellent carrier 85 candidates in immunization protocols. They are very hydrophobic and insoluble because of their carbon skeleton structure, and they have a size on the micrometer/nanometer scale, mimicking the properties and size of bacteria. If an antigen is linked to a CNT, the resulting construct could be more easily phagocytosed and rapidly introduced into the immune system, thus improving the antibody response. Pantarotto et al. [53, 54] demonstrated the potential of using CNTs for animal 90 immunization. In their seminal work, a peptide from the foot-and-mouth disease virus (FMDV) was covalently coupled to amino-derivatized single-walled carbon nanotubes (SWNTs), and this conjugate was administered to mice. Their results showed that this derivative, together with ovalbumin and an adjuvant, elicited high virus-neutralizing antibody responses in comparison with the non-conjugated peptide. Since this work, the advantages of immunization with proteins and 95 peptides using CNTs have occasionally been confirmed, [55] [56] [57] [58] but, to the best of our knowledge, no evidence of an enhancement in the immune response and antibody production against small molecules using CNTs as vehicles has been reported. The production of antibodies displaying highaffinity and specificity to haptens is an important biotechnological research field because tailor-made binders can be used to develop immunoassays and biosensors for targets such as medicinal drugs, 100 pesticides, drugs of abuse, environmental contaminants, food additives, hormones, toxins, etc.
In the present work, we explore for the first time the potential of CNTs as self-adjuvating complexes in order to amplify the antibody response to haptens. Azoxystrobin, a molecule with three aromatic rings interconnected by ether linkages (Chart 1), was selected as the model hapten for this study. Azoxystrobin was the first discovered and patented antifungal of the strobilurin agrochemical 105 family. [59] It is currently the world's best-selling proprietary fungicide with global annual sales over $1 billion,[60] which makes the development of rapid immunochemical methods for this target a desirable goal. To evaluate the efficiency of CNTs as vehicles for immunization, rabbits and mice were injected with covalent CNT-BSA-hapten constructs. Special attention was paid to the relationship between the antibody response and the CNT size and shape. Animal immunization was 110 carried out with functionalized single-and multi-walled nanotubes (SWNT and MWNT, respectively) that were either shortened or not by an acid oxidative treatment, so four types of CNTs differing in length and diameter were obtained and evaluated. The preparation of this group of functionalized CNTs was performed using fast and easy procedures based on optimized microwaveassisted chemical methods. Finally, the ability of CNTs to efficiently trigger an immune response by 115 themselves, without the need for conventional adjuvants, was also investigated.
120 Chart 1. Structure of azoxystrobin and of the AZc6 hapten. cooling. Next, the cooled reaction mixture was diluted in 250 mL of deionized water and filtered through a 0.45 m nylon membrane. The resulting black solid was collected, resuspended in 100 mL of water, sonicated, filtered again, and washed with water. Finally, the air-dried solids were suspended in deionized water at a concentration of 1 mg/mL and sonicated for 5 min to obtain stable solutions of 1a and 2a with zeta potential values of −35 and −50 mV, which were stored at 4 ºC. 165
Materials and methods

Succinic acid peroxide radical insertion procedure.
100 mg of SWNTs or 50 mg of MWNTs were suspended in 30 mL of o-dichlorobenzene in a conventional round-bottom flask, and 5 g of succinic acid peroxide were added. The mixture was sonicated for 15 min in an ultrasonic bath and then irradiated for 30 min at 115 ºC and at 250 W 170 under magnetic stirring and simultaneous air-cooling, keeping the vessel open to allow release of the CO 2 formed. After 15 min of elapsed time, additional succinic acid peroxide (5 g) was added using a solid addition funnel. After cooling, the reaction mixture was diluted with 50 mL of THF, sonicated for 15 min and then filtered through a 0.45 m nylon membrane. The black solid was collected, suspended in 50 mL of acetone, sonicated, filtered again, and washed with acetone. Finally, the air-175 dried solids were suspended in deionized water (at a concentration of 1 mg/mL) and sonicated for 5 min to obtain stable suspensions of 3a and 4a with zeta potential values of −40 and −32 mV, which were stored at 4 ºC.
Synthesis of CNT-NH 2 derivatives 1b and 3b.
80 mg of CNTs 1a or 3a were suspended in a mixture of ethylendiamine and N-methylpyrrolidone 180 (3 mL each) in a microwave quartz vessel and sonicated for 15 min. The reaction vessel was closed, and the mixture was irradiated for 30 min at 190 ºC and at 250 W under a pressure of 6 bar with magnetic stirring and simultaneous air-cooling. The cooled reaction mixture was diluted in 20 mL of THF and processed as in the previous procedure. Finally, the black solids obtained were suspended in deionized water at a concentration of 1 mg/mL and briefly sonicated to give stable suspensions of 185 1b and 3b with zeta potential values of +35 mV, which were stored at 4 ºC.
Synthesis of CNT-NH 2 derivatives 2b and 4b.
50 mg of CNTs 2a or 4a were suspended in a mixture of 3 mL of DMSO and 2 mL of N-methylpyrrolidone in a microwave quartz vessel and sonicated for 15 min. The reaction vessel 190 was closed, and the mixture was irradiated for 30 min at 180 ºC and at 280 W under a pressure of 6 bar with magnetic stirring and simultaneous air-cooling. The cooled reaction mixture was diluted in 20 mL of THF and processed as previously described to obtain 1 mg/mL aqueous stable dispersions of 2b and 4b with zeta potential values of +30 mV, which were stored at 4 ºC. 195
2.6. Synthesis of CNT-BSA-AZc6 immunizing conjugates 20 mL of a 0.1 mg/mL solution of conjugate 5 in 100 mM phosphate buffer, pH 7.4, were mixed with 20 mL of a 1 mg/mL solution of each CNT-NH 2 (1b, 2b, 3b, or 4b) in deionized water. 180 mg of EDC were added, and the resulting mixture was stirred at room temperature for 2 h. Next, the crude mixture was filtered through a 0.45 m nylon membrane and washed with water. The black 200 solid was collected, suspended in water, sonicated, filtered again, and washed. This process was repeated three times. Finally, the solids were suspended in water at a concentration of 1 mg/mL by using brief sonication to give stable solutions of the corresponding CNT-BSA-AZc6 derivatives (1c, 2c, 3c, and 4c), which showed zeta potential values between −11 and −15 mV. These solutions were stable for a long time when stored at 4 ºC. 205
Synthesis of CNT-AZc6 (3d).
100 L of a 1 mM solution of hapten AZc6 in DMF, 200 mg of EDC, and 20 mg of sulfo-NHS were consecutively added to 20 mL of a 1 mg/mL aqueous solution of 3b in 100 mM phosphate buffer, pH 7.4, and the resulting mixture was stirred for 2 h at room temperature. The CNT 210 derivative formed (3d) showed a zeta potential close to 0 mV and became insoluble in water, so they easily aggregate and precipitate. The crude mixture was filtered through a 0.45 m nylon membrane and washed, first with water and then with acetone (suspending, sonicating and filtering the solid with each solvent washing). The precipitated conjugate 3d was stored in water at 4 ºC. 215
Characterization by immuno-TEM
CNT-BSA-AZc6 aqueous solutions were deposited onto grids (a Formvar support film on a copper 400 mesh-grid). After evaporation of the solvent, samples were incubated for 2 h with a 1 g/mL solution of the specific mouse IgG anti-AZc6 mAb in 1% goat serum, washed three times with Tris-buffered saline, and incubated for 2 h with goat anti-mouse IgG-gold antibody (1/500) in 220 a Tris buffer containing 1% BSA + 0.5% Tween 20. Finally, after several washings with PBS and evaporation of the solvent, the samples were visualized using the TEM microscope.
Determination of the amount of conjugate 5 attached to the CNTs
CNT-based immunogens were diluted in PBS and analyzed in triplicate following the ELISA 225 procedure described below. For this purpose, solutions of CNT constructs were added to the plate in the competitive step with the anti-AZc6 mAb. In the case of CNT-BSA-AZc6 immunogens, standard curves of conjugate 5 in PBS were employed to interpolate the ELISA signals, whereas for the quantification of the hapten AZc6 in 3d standard curves were prepared using the hapten itself. 230
Animal immunization and antibody production
Animal manipulation was performed in compliance with Spanish laws and guidelines (RD 1201/2005 and law 32/2007) and according to the European Directive 2010/63/EU concerning the 235 protection of animals used for scientific purposes. Female BALB/c mice and New Zealand rabbits were supplied by Charles River Laboratories (L'Arbresle, France). Rabbits were immunized subcutaneously at three-week intervals with the appropriate amount of CNT derivatives. When adjuvant was used, the CNTs aqueous solution was emulsified with the same volume of complete FA for the first injection and of incomplete FA for additional doses. For each injection, a total 240 volume of 1 mL was evenly distributed among several sites along the back. When the immunization was performed without FA, 1 mL of the CNT derivative in aqueous suspension was administered at each injection. Ten days after each dose, a blood sample was taken from the ear vein, and, ten days after the fourth dose, the animals were exsanguinated by cardiac puncture. Antisera were obtained by centrifugation, diluted 1/5 with PBS containing 0.01% thimerosal, and stored at 4 ºC in amber vials 245 for daily use. For long term storage, the antisera were precipitated twice with ammonium sulfate. Eight groups of three BALB/c female mice (8−10 weeks old) were immunized at three-week intervals by intraperitoneal injections, each group with one of the described CNT-BSA-AZc6 constructs at the appropriate concentration, with or without FA. Immunogens, essentially prepared as reported above for rabbits, were administered in a total volume of 200 L per injection. An 250 additional group of mice were immunized with protein conjugate 5 (2 µg) emulsified with FA as a control. Antisera were obtained by tail bleeding 10 days after the fourth dose, diluted 1/5 with PBS containing 0.01% thimerosal, and stored at 4 ºC in amber vials.
ELISAs 255
96-well polystyrene ELISA plates were coated with 100 μL per well of the OVA-AZc6 conjugate solution (0.1 µg/mL) in 50 mM carbonate−bicarbonate buffer, pH 9.6, by overnight incubation at room temperature. The coated plates were washed four times with washing solution (150 mM NaCl containing 0.05% Tween 20), and they received 50 μL per well of the azoxystrobin solution plus 50 μL per well of the mouse or rabbit antisera. From a concentrated azoxystrobin stock solution in 260 DMF, calibration curves were prepared in borosilicate glass tubes by serial dilution in PBS. A blank was included in each curve. The competitive immunological reaction took place within 1 h at room temperature, and the plates were washed again as described. Next, 100 μL per well of the appropriate secondary HRP-labeled antibody solution in PBST (PBS containing 0.05% Tween 20) were added, and the plates were incubated for 1 h at room temperature. In the case of experiments with rabbit 265 antisera, a 1/10000 dilution of GAR−HRP was used, whereas with mouse antisera a 1/2000 dilution of the RAM−HRP conjugate was employed. After the plates had been washed as described, the colorimetric signal was generated by the addition of 100 μL per well of a freshly prepared substrate solution (2 mg/mL OPD and 0.012% (v/v) H 2 O 2 in 25 mM citrate and 62 mM phosphate buffer, pH 5.4). The enzymatic reaction was stopped after 10 min at room temperature by adding 100 μL per 270 well of 2.5 M sulfuric acid. The absorbance was immediately read at 492 nm, using 650 nm as a reference wavelength. Competitive curves were obtained by plotting mean absorbance values vs. the logarithm of analyte concentration. The resulting sigmoidal curves were fitted to a four-parameter logistic equation using the SigmaPlot software package from SPSS Inc. (Chicago, IL). The antiserum apparent affinity was estimated as the concentration of azoxystrobin at the inflection point 275 of the fitted inhibition curve, also referred to as IC 50 . Titer refers to the antiserum dilution that produces a maximum absorbance equal to 1.0 under the above described assay conditions. 280
Results and discussion
Synthesis of the CNT-based immunogens
To assess the relationship between the CNT size and shape and the triggered immune response, four types of CNT-BSA-hapten immunogens, differing in length and diameter, were prepared (Scheme 1): short and thin (1c), short and thick (2c), long and thin (3c), and long and thick (4c). 285
Previous studies on the influence of particle size on the cellular uptake and immune response were carried out with nanoparticulate materials, such as PLGA, [64, 65] 
295
Because of the stability and low reactivity of pristine CNTs, their conventional functionalization often requires harsh conditions and reaction times that can take several days. It is well known that CNTs absorb microwave energy because of their structure, [69, 70] allowing them to react more easily when using microwaves than when using conventional heating. In fact, microwave-assisted 300 chemistry has become a very attractive and useful tool for the fast and effective functionalization of CNTs in recent years. [71, 72] Accordingly, synthesis of the four types of CNTs employed in this work was accomplished using pristine SWNTs and MWNTs and rapid, straightforward procedures based on microwave-assisted chemistry. Commercial CNTs are long tubes (5-30 m), and while SWNTs are very thin (1-2 nm), MWNTs are comparatively thick (50-80 nm). We adapted and 305 optimized two general microwave methods in order to functionalize both types of CNTs with adequate moieties for hapten and conjugate coupling, i.e., acid oxidative fragmentation and succinic acid peroxide radical insertion (Scheme 1). The first procedure cuts the CNTs into fragments, inducing the opening of tube caps and the formation of holes in sidewalls. The resulting acid-cut CNT fragments are often less than 1 m in length and include carboxylate moieties at the ends and 310 on the sidewalls of the tubes. On the other hand, radical insertion methods allow the introduction of carboxy-alkyl moieties via a carboxy-alkyl radical attack on the aromatic network of the sidewalls.
This way, functional groups are introduced only on the sidewalls, and the length of the CNTs remains essentially unmodified. In the oxidative fragmentation method, SWNTs and MWNTs were treated with concentrated 315 HNO 3 at a high temperature and pressure under microwave irradiation [73] for 30 min. The progress of the carboxylation reaction was observed by measuring changes in the zeta potential values. After the reaction, acid-cut CNTs, 1a and 2a, showed excellent solubility in water (up to 1 mg/mL) and zeta potential values of −35 and −50 mV, confirming the existence of numerous negatively charged carboxylate groups on the CNT surface. 320
Incorporation of carboxylate functional groups with minor modification of the nanotube length was achieved by using a new microwave-assisted radical insertion method. Previous procedures for introducing alkyl groups into CNTs using radical insertion with acyl peroxides [61, [74] [75] [76] often involved long reaction times and/or large amounts of peroxide were consumed. We describe a new radical insertion method for alkyl chains performed under microwave conditions. Based on previous 325 work by Peng et al. , [61] we adapted the conventional heating conditions to efficiently incorporate a carboxyethyl moiety on the sidewalls of SWNTs and MWNTs through a C-C bond. The treatment of pristine CNTs with succinic acid peroxide in o-dichlorobenzene at 115 ºC under microwave irradiation shortened the reaction time from 10 days to approximately 30 min. Carboxyethyl functionalized CNTs, 3a and 4a, showed a water solubility equivalent to the acid-cut nanotubes and 330 negative zeta potential values of −40 and −32 mV, which indicate adequate functionalization of the CNT sidewall surface. The next step in the preparation of CNT-based immunogens was the introduction of an ethylendiamine moiety through a covalent amide bond between the available carboxylate groups on the CNT surface and one of the amine groups in ethylendiamine. The synthesis of these types of 335 derivatives in two steps, using conventional methods, has been previously described. [61, 77] Recently, microwave-assisted protocols have been used in order to achieve this amide bond in CNTs in only one step and without activating reagents. [78] [79] [80] Based on the procedure described by Bezdushna et al. [81] for the amidation of poly(ether sulfone) carboxylated polymers and starting from 1a and 3a, we prepared the amidated SWNTs 1b and 3b in a single 30 min step solely using 340 ethylendiamine and N-methylpyrrolidone (Scheme 1). Both types of amidated SWNTs showed zeta potential values of +35 mV. The change in the sign of the zeta potential was indicative of the negatively charged carboxylate residues on the surfaces of the CNTs being substituted by positively charged amine moieties. Like their carboxylated counterparts (CNT-COOH), these amino-aminated particles (CNT-NH 2 ) showed good water solubility, close to 1 mg/mL. 345 To achieve a direct one-step formation of the amide bond in the carboxylated MWNTs 2a and 4a, which showed a much lower reactivity, a better microwave-absorbing solvent (DMSO instead of N-methylpyrrolidone) was required. With this solvent change, it was possible to obtain the desired amido-amidated MWNTs 2b and 4b with adequate water solubility and zeta potential values (+30 mV in both cases). 350 Finally, all four types of CNT-NH 2 (1b, 2b, 3b, and 4b) were covalently coupled to the proteinhapten conjugate BSA-AZc6 (5) via an amide bond between the amine moieties on the surfaces of the CNTs and the available carboxylate groups from the aspartate and glutamate residues in the BSA-hapten conjugate (Scheme 1). Conjugate 5 was prepared [62] with a high hapten-to-protein molar ratio (MR=26), thus blocking most of the available amine residues in the protein and 355 minimizing protein cross-linking. Conjugate coupling was achieved using standard bioconjugation techniques, i.e., aqueous dispersions of each CNT-NH 2 derivative were mixed with a solution of 5 in phosphate buffer, pH 7.4, in the presence of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC) as a coupling agent. CNT-BSA-AZc6 constructs (1c, 2c, 3c, and 4c) showed zeta potential values between −11 and −15 mV and good solubility in water. Although these properties 360 qualitatively indicated that the coupling reaction had occurred, the amount of 5 attached to the nanotubes was quantified by using an ELISA to confirm this point, employing an anti-AZc6 monoclonal antibody (mAb) previously produced in our lab. [63] Loading values for 5 of approximately 18, 10, 10, and 7 g per milligram of CNT were calculated for 1c, 2c, 3c, and 4c, respectively. Instead of using other common procedures for protein quantification, such as TGA, [72, 365 76] the Kaiser test for amine residues, [53, 77] or Bradford analysis of the unbound protein,[55] the ELISA technique was chosen to estimate the protein loading in CNTs because this method gives the amount of conjugate through the interaction with the antibody, thus confirming that the hapten is actually exposed to the environment and therefore free to interact with antibodies and cell receptors during the immune response. 370
An additional CNT immunogen was prepared which comprised just the hapten AZc6 directly attached to a CNT (3d, CNT-AZc6). This construct was used as a negative control based on the widely accepted requirement of a polypeptide in order to produce antibodies against haptens. The hapten AZc6 was conjugated to the amino-aminated SWNT 3b using EDC and sulfo-NHS as coupling reagents. The immunogen 3d (Scheme 2) showed a zeta potential value close to 0 mV and 375 very poor water solubility, although it was soluble in DMF at 1 mg/mL. The concentration of AZc6 linked to CNTs, quantified by an ELISA with the anti-AZc6 mAb, was 0.26 g of hapten per milligram of CNT.
380
Scheme 2. Synthesis of the CNT-AZc6 conjugate (3d).
TEM characterization of CNT-based immunogens
Immuno-TEM was carried out to simultaneously characterize the CNT derivatives in terms of size and shape and to image the distribution of the conjugate BSA-AZc6 (5) over the CNT walls. 385
Briefly, CNT-BSA-AZc6 particles were labeled with the anti-AZc6 mAb and then incubated with a gold-labeled goat anti-mouse IgG antibody. Fig. 1 shows the immuno-TEM images of the four types of CNT-BSA-AZc6 immunogens. The sharp black dots observed in these photographs confirmed the presence of single molecules of 5 covalently immobilized on the surface of all four types of functionalized CNTs. The TEM images of 1c and 2c showed that shortened CNTs that did not 390 exceed 1 m in length (they were typically between 400 and 600 nm in length; Fig. 1A and 1B) , which proved the effectiveness of the acid-oxidation procedure for cutting CNTs into shorter segments. Derivatives 1c were visualized as individual thin needles 2 nm in diameter (Fig. 1A) , whereas 2c were imaged as individual thick tubular structures approximately 50 nm in diameter (Fig.  1B) . For 3c and 4c, the TEM images showed longer CNTs several micrometers in length (Fig. 1C  395 and 1D), thus showing that the radical insertion strategy better preserved the original length of the pristine CNTs. In the case of 3c, the diameter of each individual CNT was approximately 2 nm, but they showed a tendency to group together, forming bundles that can reach up to 100 nm in diameter (Fig. 1C) , whereas each individual 4c showed a diameter of approximately 50 nm (Fig. 1D) . Interestingly, an internal small-diameter cylindrical channel can be clearly observed in both 4c and 400 2c derivatives. 
Rabbit antibody response with CNT-based immunogens
Aqueous solutions of the four CNT-BSA-AZc6 immunogens (1c, 2c, 3c, and 4c; Table 1 ) were subcutaneously administered to rabbits with and without Freund's adjuvant (FA), which is probably the most common adjuvant for antibody production in experimental animals. The volumes were adjusted in order to inoculate the animals with 5 g of conjugate 5. CNT-AZc6 (3d) emulsified with 410 FA was also injected into control animals. Three additional controls were also employed: 5 and 50 g of 5 emulsified with adjuvant, and a mixture of 300 g of 5 with 1 mg/mL of 3b in phosphatebuffered saline (PBS). It is worthwhile noting that 5 g is a much lower amount of protein than the most frequently used dose in standard protocols for rabbit immunization (usually 0.1-1 mg).
[82] Table 1 . Main structural features of the CNT-BSA-AZc6 constructs (1c, 2c, 3c, and 4c) and the CNT-AZc6 construct (3d). 
a Oxidative fragmentation (ox) or succinic acid peroxide radical insertion (rad). b Solubility in water at 1 mg/mL. Soluble (+) or not soluble (-). c The diameter of each individual 3c construct is 2 nm, but in the TEM micrographs these tubes tend to aggregate forming bundles that could reach up to 100 nm thick.
415
The animals received a total of four doses of immunogen. Ten days after each injection they were bled, and the presence of anti-azoxystrobin antibodies in the serum samples was evaluated by ELISA. Fig. 2 shows the evolution of the immune response to azoxystrobin for each immunogen in terms of the antiserum titer ( Fig. 2A) and antibody affinity (IC 50 ; Fig. 2B ). All four types of CNT-based immunogens were capable of producing IgG responses having outstanding titers and 420 affinities to azoxystrobin. Remarkably, 5 g of conjugate was unable to trigger a significant response when administered alone, i.e., not attached to CNTs (legend "5 (1×) + FA" in Fig. 2A ). In fact, it was necessary to use an amount of conjugate 10-fold larger (50 g) in order to achieve a nearly equivalent output (legend "5 (10×) + FA" in Fig. 2A ). In our opinion, these results showed the practical capability of CNTs for enhancing the immune response against haptens by acting as 425 efficient delivery vehicles. More important, CNTs worked very effectively as immunizing carriers even in the complete absence of FA, as injections with aqueous solutions of CNT-BSA-AZc6 constructs demonstrated. Although slightly lower titers were obtained ( Fig. 2A) , anti-azoxystrobin antibodies produced from CNT immunogens without FA showed affinities comparable to or even better than those obtained with the positive control (Fig. 2B) . Moreover, the fact that the titers 430 gradually increased with booster doses, whereas the IC 50 values decreased down to 1 nM, is indicative of a regular affinity maturation process. To the best of our knowledge, this is the first reported evidence supporting the self-adjuvanting 445 capacity of CNTs for the production of high-affinity antibodies. CNT immunogens are comparable in shape and size to bacteria, so they can be very easily phagocytosed by APCs, which most likely makes the immunostimulatory effect of classical adjuvants unnecessary. This finding has interesting applications for the routine production of antibodies with biotechnological and diagnostic purposes, because immunizations without classical adjuvants are much easier, cheaper, faster, and less painful 450 for animals. The contraindications and negative health effects of the adjuvants employed in animal experimentation, including FA, have been widely described, [67, 83] and the painful consequences for the skin are also well known. In our experiments, rabbits showed no skin damage, no wounds, and no apparent negative reactions when subcutaneously injected with CNT constructs in buffer. In line with our results, excellent examples of the production of anti-hapten antibodies using different 455 nanoparticles as safe delivery vehicles have been recently reported for several low molecular weight chemicals. [67, 68] No IgG response against azoxystrobin was observed in rabbits immunized with 3d + FA (without carrier protein) or with the 5 + 3b mixture (no covalent linking with the CNT). The absence of a response with 3d confirms the paradigm that a protein is required for the effective production of 460 anti-hapten antibodies. Although nanoparticles increase the size of the immunogen and allow a better uptake by macrophages, only peptide fragments generated after antigen processing can be linked to MHC II molecules on the APCs surfaces. [14] Nevertheless, Maquieira et al. [68] have recently reported the existence of a secondary immune response with haptens covalently linked to aluminum oxide nanoparticles, even though further research is probably required to fully clarify the underlying 465 mechanism. On the other hand, the lack of response with the 5 + 3b mixture shows that non-covalent interactions between the positively charged CNT 3b and the negatively charged protein conjugate 5 are not sufficient to preserve the integrity of the immunogen; so, a covalent bond between the CNT and the protein-hapten conjugate is needed for proper antigen delivery inside cells. Finally, Fig. 2 reveals significant differences in the antibody response as a function of CNT size 470 and shape. Our results indicate that CNT vehicles with similar diameters work better if they have shorter lengths. Thus, construct 2c elicited higher titers and better affinities than 4c, and 1c also evoked higher titers than 3c, though similar affinities. Construct 4c turned out to be the worst immunogen, whereas 2c clearly displayed the best performance, exhibiting the highest titer and the best affinity after the last immunization (IC 50 =1 nM), both with and without FA. 475
To gain further insight into the amplifying effect observed for CNT-based constructs, the four immunogens were additionally assessed by immunizing animals with a 10-fold lower amount of protein conjugate 5 (0.5 µg per rabbit). Additionally, immunogen 2c was also evaluated at an even lower dose (0.05 µg of conjugate 5). As shown in Table 2 , significant IgG responses were still observed for all four CNT-based immunogens at these low doses (with titers ranging from 1/100 to 480 1/5000, depending on the type of CNT), whereas no response was observed as before when 5 ug of conjugate 5 was administered by conventional protocols, i.e., without being covalently bound to CNTs. Furthermore, titers close to 1/1000 and IC 50 values lower than 10 nM were still obtained in rabbits immunized with 0.05 µg of 2c, still the best-performing CNT construct. These results confirm that CNTs could be useful as delivery systems for obtaining strong antibody responses even 485 with antigen amounts 1000-fold lower than typical doses used for rabbit polyclonal antibody production. 
490
Remarkably, azoxystrobin competitive inhibition curves with rabbit antisera obtained from immunogen 2c at different doses perfectly fitted a four-parameter logistic equation, displaying analytical features equivalent to those of the curve with a rabbit antiserum that was obtained under standard immunization conditions (Fig. 3) . 495 
Mouse antibody response with CNT-based immunogens
Additional immunization experiments were carried out on mice -a widely used animal model for experimental research and particularly for the production of monoclonal antibodies. Groups of 3 510 mice were immunized intraperitoneally with 2 g of protein conjugate 5 attached to each CNT derivative, either in aqueous solution or emulsified with FA. As a control, an additional group of 3 mice was immunized with 2 g of 5 in FA without CNT. Each animal received a total of four injections. Ten days after the fourth dose, blood samples were taken, and the antisera were assessed by ELISA. All of the CNT-based immunogens elicited a strong IgG response, displaying titers even 515 higher than the control, particularly for the shortest particles. This result confirmed 1c and 2c as the best constructs for antibody production also in mice and through a different inoculation route (Fig.  4) . Moreover, antisera from immunogens 1c and 2c also showed superior affinity to the target, with azoxystrobin IC 50 values lower than 50 nM. The most important result emerging from this immunization experiment is the unequivocal capability of CNT-based immunogens to trigger 520 equivalent IgG responses with and without FA, thus further proving the self-adjuvanting properties of CNTs. 
Conclusions
We have employed microwave-assisted procedures to achieve fast and easy covalent 530 functionalization of SWNTs and MWNTs, introducing carboxylate moieties that were subsequently reacted with ethylendiamine to incorporate amine residues. The reactions of these aminated CNTs with protein-hapten conjugate 5 gave the corresponding immunogenic derivatives. The initial application of the radical insertion or oxidative fragmentation methods for both types of pristine CNTs resulted in four types of CNT immunogens, differing in shape and size. The ELISA and 535 immuno-TEM techniques allowed detailed characterization of the prepared immunogens, ensuring that the hapten was properly exposed to the surrounding medium and therefore to the immune system. The obtained antisera displayed excellent titers and affinities to the model hapten, thus showing the capability of CNTs to act as vehicles for enhancing the immune response, even with low amounts of a protein conjugate. This result opens the door to the biotechnological possibility of 540 producing valuable antibodies for other haptens or even whole proteins, particularly if they are difficult to obtain and purify in the quantities required for conventional immunization protocols. Moreover, CNT-based immunogens were able to work very efficiently even without conventional water-in-oil adjuvants, acting as "bacteria-like" antigens with a self-adjuvanting capacity. This finding, beyond its relevance for basic science and its interest as proof-of-concept, could have 545 important practical implications in antibody production because immunization procedures not involving mineral oil adjuvants are faster, cheaper and less painful to animals. Finally, CNT-based immunogens behaved differently depending on the size and shape of their particles. The shorter immunogens (1c and 2c) produced better responses than the longer ones (3c and 4c), most likely because CNTs less than 1 µm long are better phagocytosed and engulfed by APCs, although other 550 characteristics associated with the nanoparticle size, such as hydrophobicity and surface antigen density, cannot be discarded. Overall, short and thick CNTs constructs (2c) performed optimally as delivery vehicles, producing suitable IgG responses even when loaded with just 0.05 µg of the protein conjugate. 555
